OZOLEX 40mg/Vial Injection/Lyophilized powder for

What is OZOLEX 40mg/Vial

OZOLEX 40mg/Vial is a parenteral formulation of Omeprazole sodium, presented as a lyophilized powder for injection. It is intended for intravenous (IV) use, typically when oral administration is not feasible or in emergency situations.

• Active Ingredient: Omeprazole sodium equivalent to 40 mg Omeprazole per vial.
• Form: Lyophilized powder supplied in a glass vial, reconstituted with sterile water for injection before administration.
• Indications: Used in the management of acid-related gastrointestinal disorders such as severe gastroesophageal reflux disease (GERD), Zollinger-Ellison syndrome, gastric ulcers, erosive esophagitis, and prevention of stress ulcers in critically ill patients.
• Use Case: Particularly beneficial in hospitalized patients who cannot take oral medication due to conditions such as nausea, vomiting, or mechanical ventilation.
• Therapeutic Benefit: Provides rapid and effective suppression of gastric acid secretion, promoting healing and symptom relief.

OZOLEX 40mg/Vial is an essential medication in inpatient and emergency settings where rapid acid control is necessary and oral administration is impractical.

How to use OZOLEX 40mg/Vial

Correct preparation and administration of OZOLEX 40mg/Vial are critical for safety and efficacy. Below are detailed instructions:

• Reconstitution: Before use, reconstitute the lyophilized powder with the supplied ampoule of sterile water for injection. Gently swirl until the powder fully dissolves, resulting in a clear solution.
• Administration Route: Administer the reconstituted solution intravenously, typically via slow IV injection or infusion over 3 to 30 minutes as directed by healthcare professionals.
• Dosage Frequency: The dosing schedule depends on the clinical condition, usually once or twice daily, based on physician prescription.
• Monitoring: Patients should be monitored for response and any adverse effects during treatment.
• Compatibility: Avoid mixing with other medications in the same IV line unless compatibility is confirmed. Use separate lines when possible.
• Use in Hospital Setting: This medication should be administered by trained healthcare professionals in a controlled environment.
• Missed Dose: If a dose is missed, it should be given as soon as possible unless the next dose is imminent. Do not double doses.

Always follow the healthcare provider’s instructions carefully to ensure effective and safe use of OZOLEX 40mg/Vial.

Mode of Action OZOLEX 40mg/Vial

OZOLEX 40mg/Vial exerts its therapeutic effects by inhibiting gastric acid secretion through a highly specific mechanism:

• Proton Pump Inhibition: Omeprazole sodium targets and irreversibly inhibits the hydrogen-potassium ATPase enzyme (proton pump) found on gastric parietal cells, which is the final step in acid secretion.
• Acid Reduction: By blocking the proton pump, it suppresses the secretion of hydrogen ions into the stomach lumen, resulting in a significant and sustained decrease in gastric acidity.
• Duration of Action: Because the binding is irreversible, acid secretion remains inhibited until new proton pumps are synthesized by the cells, allowing for prolonged acid suppression beyond the plasma half-life of the drug.
• Effect on Disease: The reduced gastric acidity allows ulcers and erosions to heal, reduces symptoms of reflux and acid-related pain, and creates a less favorable environment for pathogens like Helicobacter pylori.
• Rapid Onset: The injectable form allows for faster achievement of therapeutic drug levels, important in acute and severe clinical scenarios.

This targeted mechanism underlies the effectiveness of OZOLEX 40mg/Vial in managing severe acid-related gastrointestinal conditions.

OZOLEX 40mg/Vial Interactions OZOLEX 40mg/Vial

OZOLEX 40mg/Vial, like oral Omeprazole, can interact with various drugs by altering gastric pH or affecting liver enzymes:

• Clopidogrel: Omeprazole may reduce activation of clopidogrel via CYP2C19 inhibition, potentially decreasing its antiplatelet effect and increasing cardiovascular risk.
• Drugs Requiring Acidic Stomach: Medications such as ketoconazole, itraconazole, atazanavir, and iron salts depend on an acidic environment for absorption. Omeprazole’s acid suppression can reduce their bioavailability.
• Warfarin and Anticoagulants: Omeprazole may increase bleeding risk by affecting platelet function or interacting pharmacokinetically, necessitating close monitoring.
• Diazepam, Phenytoin, and Theophylline: Metabolism can be inhibited, leading to higher blood concentrations and increased risk of toxicity.
• Digoxin: Plasma levels may rise, requiring therapeutic monitoring.
• Other Proton Pump Inhibitors or Antacids: Co-administration should be monitored to avoid excessive acid suppression.
• Rilpivirine: Concurrent use is contraindicated due to reduced absorption and potential treatment failure.

It is important to inform healthcare providers of all concomitant medications to avoid adverse drug interactions.

Dosage of OZOLEX 40mg/Vial

Dosage of OZOLEX 40mg/Vial depends on clinical indication and patient condition, with the following typical regimens:

• Gastroesophageal Reflux Disease (GERD) and Erosive Esophagitis: 40 mg IV once daily for 4 to 8 weeks or as clinically indicated.
• Zollinger-Ellison Syndrome: Initial dosing usually starts at 60 mg IV daily, titrated according to acid output; divided doses may be necessary.
• Peptic Ulcer Disease: 40 mg IV once daily for 4 to 8 weeks.
• Stress Ulcer Prophylaxis: 40 mg IV once daily, particularly in critically ill or mechanically ventilated patients.
• Helicobacter pylori Eradication: Usually administered in combination with antibiotics, dosage and duration tailored by physician.
• Special Populations: Dose adjustments may be necessary in patients with hepatic impairment; careful clinical assessment is required.

Dosing should always follow physician recommendations and be individualized based on therapeutic response and tolerance.

Possible side effects of OZOLEX 40mg/Vial

Although OZOLEX 40mg/Vial is generally well tolerated, potential side effects may occur, including:

• Common Side Effects:
• Headache
• Nausea and vomiting
• Abdominal pain and discomfort
• Diarrhea or constipation
• Injection site reactions (pain, redness)
• Less Common Side Effects:
• Dizziness
• Rash or itching
• Elevated liver enzymes
• Vitamin B12 deficiency with long-term use
• Rare but Serious Side Effects:
• Severe allergic reactions including anaphylaxis
• Clostridium difficile-associated diarrhea
• Acute interstitial nephritis
• Hypomagnesemia with prolonged treatment
• Bone fractures (with chronic use)

Patients should be monitored closely, especially if symptoms of serious adverse effects appear, and report any unusual symptoms immediately.

OZOLEX 40mg/Vial Contraindications OZOLEX 40mg/Vial

OZOLEX 40mg/Vial should not be used in the following conditions:

• Known Hypersensitivity: Allergy to Omeprazole, other proton pump inhibitors, or any component of the formulation.
• Concurrent Use with Rilpivirine: Contraindicated due to risk of reduced efficacy of rilpivirine.
• Undiagnosed Gastric Malignancy: Use may mask symptoms, delaying diagnosis.
• Severe Liver Disease: Use with caution; dose adjustment may be required.
• Pediatric Use: Safety and efficacy not well established in children under 1 year.

Always disclose your full medical history to your healthcare provider to ensure safe use.

Storage of OZOLEX 40mg/Vial

Proper storage is essential to maintain drug stability and safety:

• Temperature: Store lyophilized powder and sterile water ampoules at controlled room temperature, generally between 20°C to 25°C (68°F to 77°F).
• Protection: Keep away from direct light and moisture to prevent degradation.
• Packaging: Keep in original packaging until use to maintain sterility and potency.
• After Reconstitution: Use the solution immediately after preparation or within the time frame specified by the manufacturer and hospital protocol. Do not refrigerate reconstituted solution unless advised.
• Safety: Store out of reach of children and unauthorized personnel.
• Expiration: Do not use beyond the expiration date indicated on the vial or packaging.

Following these storage guidelines helps ensure OZOLEX 40mg/Vial remains effective and safe during its shelf life.